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Cardiac rehabilitation (CR) in heart failure (HF) improves exercise capacity and quality of life, reduces rehospitaliza-
tions, and prolongs survival. Systematic referral of HF patients to CR, especially during the vulnerable phase after a 
congestive episode, is strongly recommended. However, CR in HF is still largely underused.
CR is a multidisciplinary approach of complete secondary prevention that can be realized in most HF patients on an 
outpatient basis in 2-3 months. The CR team includes cardiologists, physiotherapists, dieticians, HF nurses, social 
workers, and psychologists.
Cardiopulmonary exercise testing (CPX) is a fundamental tool to evaluate the impaired exercise capacity and oxygen 
uptake of HF patients. The core component of the CR program is individually tailored exercise training (ET) with en-
durance and resistance training units. During CR, the patients benefi t from an effi cient adaptation of pharmacotherapy 
by HF specialists, individual and group-based patient education, dietary counselling, structured tobacco cessation 
programs, and psycho-social support.
The benefi cial effects of ET are both cardiac and peripheral, including reduction of resting heart rate by improved 
control of autonomic imbalance, increase of the chronotropic reserve, decrease of peripheral vascular resistance, and 
improved aerobic metabolism of the skeletal muscle resulting in increased endurance and force.
Key unresolved issues remain the low referral rate of HF patients to CR by acute care cardiologists, the limited capacity 
of CR centers to absorb all referred patients, and especially the diffi culties to motivate HF patients to maintain a suffi ci-
ent level of physical activity after discharge from CR.
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Introduction
The prevalence of chronic heart failure (HF) is rapidly 
increasing among older adults in developed countries 
due to the prolonged survival of patients, resulting from 
spectacular improvements in drug and device therapy. 
Thus, health care professionals have to provide optimal 
medical care to a growing number of chronic HF pati-
ents presenting exercise dyspnea and recurrent con-
gestive episodes. The main objectives of this care are 
to limit fl uid retention, to stop worsening of the left vent-
ricular (LV) function and remodeling, to improve exerci-
se capacity, to reduce exercise-induced dyspnea, and 
to reduce mortality.
The cornerstones of HF care, in particular following a 
congestive episode, are the stepwise optimization of 
drug treatment (titration), exercise training, patient edu-
cation, management of uncontrolled risk factors, and if 
necessary psychosocial support. Cardiac rehabilitation 
(CR) centers are best suited and qualifi ed to provide 
this complex, specialized, time-consuming, and mult-
idisciplinary care. Therefore, referral of HF patients to 
CR has obtained the highest possible level of recom-
mendation in current guidelines (class I, level A) (1). Ne-
vertheless, the implementation of CR in HF is still very 
low, especially in women and in elderly patients (2).
Patient education is fundamental to avoid or at least 
delay decompensations, and to reduce their gravity by 
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early recognition of worsening symptoms allowing for 
rapid therapeutic intervention, ideally on an outpatient 
basis. This goal can only be achieved if the patient:
1.  becomes an informed and responsible actor of his 
own pathological condition by understanding the 
causes of HF;
2.  becomes aware of all factors that can favor fl uid re-
tention;
3.  becomes able to self-monitor his own symptoms and 
to recognize the precursor signs of an impending de-
compensation;
4.  understands the crucial importance of uninterrupted 
drug treatment;
5.  and becomes able to seek professional help as early 
as possible. These objectives require a structured 
and individualized patient education provided by a 
multidisciplinary team consisting of specialized HF 
nurses, HF cardiologists, physiotherapists, and die-
ticians.
Benefits of CR in HF
The most important factor impacting on the quality of 
life of HF patients is exercise dyspnea, which in turn 
depends not only on the degree of cardiac dysfunction 
and the control of volemia and fi lling pressures, but also 
on peripheral dysfunctions involving decreased aero-
bic performance of the skeletal muscle, neurohormonal 
activation contributing to increase heart rate and perip-
heral vascular resistance, endothelial dysfunction, and 
chronic low-grade infl ammation.
Exercise training (ET) allows lowering the resting heart 
rate (3) and consequently to improve the control of LV 
fi lling pressures refl ected by a signifi cant decrease 
in natriuretic peptide levels (4). However, the key pat-
hophysiological mechanisms underlying the positive 
effect of ET are peripheral, by increasing skeletal musc-
le mass, force, and endurance, by reducing the level 
of circulating catecholamines and by reducing the ac-
tivation of the renin-angiotensin- aldosterone system, 
by improving the endothelium- dependent arteriolar va-
sodilation, and by limiting pro-infl ammatory cytokines. 
Altogether, these mechanisms contribute to increase 
the chronotropic reserve, improve heart-rate variability, 
reduce LV afterload, and optimize oxygen supply and 
aerobic metabolism of the skeletal muscle.
Physical training in HF patients has indeed been pro-
ven to increase peak oxygen consumption (VO2) and 
exercise duration by approximately 20%. These imp-
rovements in exercise capacity are paralleled by a 
reduction of morbidity-mortality by about 30% (5, 6). 
There is growing evidence that benefi ts of CR obser-
ved in HF with reduced ejection fraction (EF) are lar-
gely reproducible in patients with HF with preserved 
EF, and that CR should therefore be extended to this 
population (7).
Cardiopulmonary exercise testing
Historically, HF patients were advised to prolonged bed 
rest after a large myocardial infarction and/or after a 
severe congestive episode in order to “preserve” their 
already “tired” heart. Over the past decades, the revolu-
tionary progress in the understanding of the pathophy-
siological mechanisms of HF and of the fundamental 
role of the peripheral musculature have initiated a pa-
radigm shift, encouraging early referral of HF patients 
to CR. Indeed, prolonged bed rest provokes peripheral 
deconditioning characterized by a quantitative and a 
qualitative loss of skeletal muscle mass and function, 
resulting in amyotrophy, downregulation of key enzy-
mes of muscle oxidative metabolism such as citrate 
synthase and cytochrome c oxidase, microvascular ra-
refaction, and increased systemic vascular resistance, 
all of them contributing to reduce exercise capacity and 
tolerance in HF patients.
Cardiopulmonary exercise testing (CPX) is a funda-
mental tool to evaluate the impaired exercise capacity 
and oxygen uptake of HF patients in CR centers (Fi-
gure 1). In contrast to standard exercise testing, CPX 
allows to determine a.o. the fi rst ventilatory threshold 
(VT1) that indicates transition from oxidative to anaero-
bic muscle metabolism, and to determine the peak oxy-
gen consumption (VO2), both of them carrying crucial 
functional and prognostic signifi cance. The interpreta-
tion of CPX in HF requires a profound knowledge of 
cardiovascular, respiratory, and peripheral adaptations 
to exercise, since it integrates the capacity of the lungs 
to oxygenate hemoglobin, the capacity of the cardio-
vascular system to transport oxygenated hemoglobin to 
the periphery, and the capacity of the skeletal muscle to 
uptake and metabolize oxygen.
Indeed, CR cardiologists are particularly aware of the 
fact that pathologically reduced peak VO2 of HF pati-
ents can result from both reduced cardiac pump func-
tion (central dysfunction) and from reduced muscular 
oxygen uptake (peripheral dysfunction). Thus, impaired 
peak VO2 in HF does not necessarily refl ects critically 
reduced cardiac output and catastrophic prognosis, but 
can at least in part result from profound peripheral de-
conditioning. On the other hand, peak VO2 can be found 
relatively preserved in severe HF patients with very low 
LVEF, which can be explained by preserved skeletal 
muscle mass and oxidative function as a result of exerci-
se training (ET). In other terms, impaired VO2 in HF pati-
ents reliably refl ects impaired cardiac pump function only 
in the absence of signifi cant peripheral deconditioning. 
Consequently, the measurement of peak VO2 before ET 
has a limited prognostic value, whereas it is one of the 
best prognostic markers in HF patients after completion 
of an individualized ET program (8). Far-reaching ther-
apeutic decisions such as heart transplantation or the 
need for LV assistance should therefore be based on 
CPX results obtained after completion of a CR program.
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Exercise training: a core component of CR 
in HF
Exercise training constitutes therefore a fundamental 
element of care of HF patients in CR centers, aimed at 
increasing aerobic exercise capacity that has been pro-
ven not only to improve exercise tolerance and thereby 
quality of life, but also life expectancy (9). The prescrip-
tion of an individualized ET program requires, after ex-
clusion of contraindications to exercise such as hemody-
namic instability or signifi cant ventricular arrhythmias, a 
careful and precise evaluation of the exercise capacity at 
admission by an incremental and maximal (symptom-li-
mited) exercise test, if possible coupled to the measure-
ment of ventilation and gas exchange (CPX). This eva-
luation allows to estimate the degree of deconditioning, 
to estimate the minimum number of training sessions ne-
eded, and to determine the intensity of the fi rst enduran-
ce training units at the aerobic threshold (VT1).
After the initial evaluation of contraindications and 
exercise capacity by the CR cardiologist, HF patients 
participate under supervision of experienced physiot-
herapists in about 20-30 endurance training units of 
30-45 min. each, in groups of 8-12 patients, usually on 
ergocycles or treadmills, if possible on an outpatient 
basis (Figure 2). Due to the individually adjusted wor-
kload for each patient on each ergocycle, this setting 
allows to provide an individually tailored ET program 
while benefi ting from the positive psychological effects 
of a group-based approach. Beyond endurance trai-
ning, the ET program should also comprise resistance 
training units for segmental reinforcement (Figure 3), 
group gymnastics (Figure 4), and active relaxation. In 
a growing number of CR centers patients can benefi t 
from more original and therefore more motivating phy-
sical activities such as Tai Chi or yoga.
Secondary prevention in CR centers
HF patients go through a particularly vulnerable period 
during the fi rst weeks after a congestive episode, when 
pharmacotherapy needs to be readjusted and residual 
congestion must be resolved, physical deconditioning 
is particularly pronounced due to prolonged bed rest, 
and anxiety/depression can be predominant. More 
than half of hospital readmissions occur during the fi rst 
month after discharge. The complexity and the gravity 
of this clinical situation require a careful and standar-
dized post-discharge management at the end of the 
acute care. Referral of these patients to CR centers al-
lows to effi ciently addressing all residual and modifi ab-
le problems in a secure environment by a specialized 
multidisciplinary team.
At the end of the acute care following decompensation, 
most of the HF patients still present a signifi cant sub-cli-
nical residual congestion, which is known to favor early 
readmissions. The elimination of residual congestion, i.e. 
titration of the baseline (or “dry”) weight and of the base-
line NT-proBNP levels refl ecting the lowest possible LV 
fi lling pressures for each patient, needs time and care-
ful adjustment of diuretic therapy to avoid symptomatic 
blood pressure drop and worsening of the renal functi-
on. The fast and safe removal of residual congestion not 
only reduces the risk of repeated decompensations, but 
also reduces exercise dyspnea and favors exercise tole-
rance, facilitating rapid reconditioning.
During decompensation, pharmacotherapy with beta 
blocker and/or inhibitors of the renin-angiotensin-aldos-
terone system is usually reduced or even stopped in 
case of hemodynamic instability and/or worsening of 
renal function. These drugs must be safely up-titrated 
to provide again, and as soon as possible, effi cient pro-
FIGURE 1. Cardiopulmonary exercise testing
FIGURE 2. Endurance training
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tection against neurohormonal activation and LV remo-
deling. CR centers provide the best possible care with 
regard to optimization of pharmacotherapy after a con-
gestive episode for two main reasons: fi rst, HF patients 
are closely monitored by specialists allowing for shorter 
titration intervals whit systematic control of hemodyna-
mic and biological tolerance of each titration step, and 
second, improved exercise capacity favors the hemo-
dynamic tolerance in particular of betablocker therapy, 
allowing for a more rapid up-titration.
The most effective approach to avoid future decompen-
sations is probably patient education. The risk of decom-
pensation is markedly reduced if the HF patient has un-
derstood the crucial importance of uninterrupted drug 
treatment and is able to identify possible side effects; if 
he is aware of the link between salt intake and fl uid re-
tention, and is able to estimate the salt content of foods; 
if he has understood the importance of regular weight 
control and knows when, how and who to alert in case 
of signifi cant weight gain; if he is aware of the link bet-
ween deconditioning and exercise intolerance, and thus 
of the importance of regular physical exercise; and if 
he has understood the importance of a well-organized 
specialized follow-up with regular offi ce consultations. 
Therefore, CR centers offer structured patient education 
programs addressing all these issues, starting with an 
individual evaluation of knowledge and motivation, fol-
lowed by group-based thematic workshops (Figure 5).
The integrated care in CR centers addresses not only 
HF and deconditioning, but also the control of all risk 
factors (RF) potentially favoring disease progression. 
In HF patients with coronary artery disease, the most 
frequent cause of HF in developed countries, the parti-
cipation in a complete CR program usually allows to ob-
tain an optimal control of all modifi able CVRF such as 
hypertension, hypercholesterolemia, and diabetes. Fi-
nally, CR centers offer professional psychological sup-
port in case of marked depression and/or anxiety, smo-
king cessation programs, addictology support in case 
of alcoholism, social assistance in case of professional 
diffi culties or social isolation.
Post-discharge management
The Achilles’ heel of CR in HF patients remains the main-
tain of the benefi ts at long term (10). The most important 
and still largely unmet challenge is to motivate HF pati-
ents to continue regular endurance ET after discharge 
from the CR center. This goal is much more challenging 
than to obtain optimal compliance for drug therapy and 
CVRF control, since regular ET is time-consuming, and 
requires a particularly high motivational level and re-or-
ganization of the personal time schedule. In younger HF 
patients, ET training sessions might be diffi cult to integ-
rate into the daily life due to professional and/or fami-
liar constraints. In elderly patients, transport problems, 
social isolation, and/or musculoskeletal comorbidities 
frequently limit the maintain of CR benefi ts at long term.
Conclusions
CR in HF is benefi cial and therefore strongly recom-
mended, however largely underused due to lack of re-
ferral and/or limited capacity of CR centers. CR impro-
ves cardiac and peripheral muscle function, improves 
thereby exercise capacity and exercise tolerance resul-
ting in increased quality of life, and signifi cantly reduces 
morbidity and mortality. The benefi cial effects of CR 
are observed not only in HFrEF, but also in HFpEF pati-
ents. The most important unresolved question in CR is 
how to maintain patient motivation to continue exercise 
training after discharge.
FIGURE 4. Group gymnastics FIGURE 5. Group-based therapeutic education
FIGURE 3. Resistance training
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